| |
| |
| |
| |
| | | |
|
PR:000000095 | tumor necrosis factor ligand superfamily member 6 | | | | | |
| | | | |
|
PR:000000276 | tumor necrosis factor ligand superfamily member 6 isoform FasL | | | | | |
| | | | | |
|
PR:P48023-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (human) | | | | | |
| | | | | | |
|
PR:000036458 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | | | | | |
| | | | | | |
|
PR:000036782 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |
| | | | | |
|
PR:P41047-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) | | | | | |
| | | | | | |
|
PR:000036783 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | | | | | |
| | | | | |
|
PR:000000432 | tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form | | | | | |
| | | | | | |
|
PR:000000546 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 | | | | | |
| | | | | | | |
|
PR:000036458 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000000278 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L | | | | | |
| | | | | | |
|
PR:000036782 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | | | | | |
| | | | | | |
|
PR:000036783 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | | | | | |
| | | | | |
|
PR:000000547 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |